Case number 1:23-cv-00819
Astellas Pharma Inc. et al v. Lupin Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 23, 2024 | 279 | Amended Complaint* (1) |
| Jul 3, 2024 | 247 | [SEALED] Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Reply In Further Support - re 242 MOTION for Teleconference to Resolve Discovery Dispute . (Attachments: # 1 Exhibit 1-4, # 2 Certificate of Service)(Silver, Daniel) (Entered: 07/03/2024) (0) |
| Jun 27, 2024 | 246 | Letter to The Honorable Christopher J. Burke from Pilar G. Kraman regarding Responsive Discovery Dispute Letter - re 242 MOTION for Teleconference to Resolve Discovery Dispute . (Attachments: # 1 Exhibit B - C)(Kraman, Pilar) (Entered: 06/27/2024) (0) |
| Jun 21, 2024 | 244 | NOTICE OF SERVICE of 1) Defendants Zydus Pharmaceuticals (USA) Inc.'s and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Third Set of Interrogatories to Zydus (Nos. 4-10); and 2) Defendants Zydus Pharmaceuticals (USA) Inc.'s and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Requests to Zydus for the Production of Documents and Things (Nos. 1-7) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 06/21/2024) (2) |
| Jun 21, 2024 | 245 | NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' Third Set of Interrogatories (Nos. 4-10) and Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-7) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 06/21/2024) (2) |
| Jun 20, 2024 | 242 | MOTION for Teleconference to Resolve Discovery Dispute - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 06/20/2024) (2) |
| Jun 20, 2024 | 243 | Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Plaintiffs' Letter In Support of Motion for Teleconference to Resolve Discovery Dispute - re 242 MOTION for Teleconference to Resolve Discovery Dispute . (Attachments: # 1 Exhibit A, # 2 Text of Proposed Order)(Silver, Daniel) (Entered: 06/20/2024) (0) |
| Jun 14, 2024 | 240 | ORAL ORDER: The Court, having reviewed the parties’ June 13, 2024 letter requesting a discovery teleconference, (D.I. 239 ), hereby ORDERS as follows: (1) A discovery dispute videoconference using the Microsoft Teams platform is set for August 5, 2024 at 1:30 p.m. before Judge Christopher J. Burke.; (2) By June 20, 2024, Plaintiffs shall file a "Motion for Videoconference to Resolve Discovery Dispute," the text of which can be found in the "Forms" tab on Judge Burke's portion of the District Court's website; (3) By June 20, 2024, Plaintiffs shall file with the Court a letter, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining the issue in dispute and their position on that issue. By June 27, 2024, Defendants shall file with the Court a letter, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining the reasons for their opposition. By no later than July 3, 2024, Plaintiffs shall file with the Court a reply letter brief, not to exceed one (1) single-spaced page, in no less than 12-point font.; (4) By no later than July 26, 2024, the parties shall send an e-mail to the Court's Courtroom Deputy, Ms. Grimes, indicating the names and e-mail addresses of all individuals who will participate in the videoconference.; (5) The parties should also consult and follow Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; and (6) The Court may choose to resolve the dispute prior to the videoconference and will, in that event, cancel the videoconference (however, if any party advises the Court in advance that a newer attorney will argue the dispute, see Standing Order Regarding Courtroom Opportunities for Newer Attorneys, https://www.ded.uscourts.gov/sites/ded/files/StandingOrder2017.pdf, then the Court will go forward with the conference). Ordered by Judge Christopher J. Burke on 06/14/2024. (smg) (Entered: 06/14/2024) (0) |
| Jun 14, 2024 | 241 | NOTICE OF SERVICE of (1) Astellas' Reply Claim Construction Brief and (2) Declaration of Vincent Li, Esq. In Support of Astellas' Reply Claim Construction Brief with Exhibits 25-31 filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Silver, Daniel) (Entered: 06/14/2024) (3) |
| Jun 13, 2024 | 238 | STIPULATION TO EXTEND TIME regarding Claim Construction Briefing to See Stip for Details - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 06/13/2024) (3) |
| Jun 13, 2024 | 239 | Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Scheduling a Teleconference. (Silver, Daniel) (Entered: 06/13/2024) (2) |
| Jun 13, 2024 | N/A | SO ORDERED, D.I. 238 Stipulation to Extend Time regarding Claim Construction Briefing - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. Ordered by Judge Christopher J. Burke on 06/13/2024. (smg) (Entered: 06/13/2024) (0) |
| Jun 7, 2024 | 236 | Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Discovery Dispute Teleconference. (Silver, Daniel) (Entered: 06/07/2024) (1) |
| Jun 7, 2024 | 237 | ORAL ORDER: The Court, having reviewed Plaintiffs’ June 7, 2024 letter regarding a discovery dispute it wishes to raise with the Court (“letter”), (D.I. 236 ), hereby ORDERS that counsel participate in a verbal meet and confer to discuss the issue Plaintiffs raise in the letter and whether they can resolve the issue without the Court’s intervention. By no later than June 14, 2024, the parties shall file a letter of no more than one (1) single-spaced page, indicating whether they have been able to resolve the issue. If the parties have not been able to resolve the issue, the Court will then set a briefing schedule. Ordered by Judge Christopher J. Burke on 06/07/2024. (smg) (Entered: 06/07/2024) (0) |
| Jun 6, 2024 | 235 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Zydus's Second Set of Requests for Production (No. 2) and (2) Plaintiffs' Objections and Responses to Defendants' Second Set of Interrogatories (Nos. 4-5) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 06/06/2024) (3) |
| Jun 5, 2024 | 232 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Lupin Limited and Lupin Pharmaceuticals, Inc.'s Second Set of Requests for Production (No. 2) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 06/05/2024) (2) |
| Jun 5, 2024 | 233 | NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Supplemental Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 06/05/2024) (2) |
| Jun 5, 2024 | 234 | USCA Order Terminating Appeal as to 211 Notice of Appeal (Federal Circuit), filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. USCA Decision: The proceeding is DISMISSED under Fed. R. App. P. 42 (b). Each side shall bear their own costs. (jfm) (Entered: 06/06/2024) (2) |
| May 29, 2024 | N/A | CORRECTING ENTRY: Previous stipulation has been removed per request of counsel. Filed erroneously. (smg) (Entered: 05/29/2024) (0) |
| May 22, 2024 | 231 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-7) and (2) Plaintiffs' Third Set of Interrogatories to Defendants (Nos. 4-10) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Silver, Daniel) (Entered: 05/22/2024) (3) |
| May 17, 2024 | 230 | NOTICE OF SERVICE of 1) Defendants' Joint Answering Claim Construction Brief; and 2) Declaration of David B. Abramowitz in Support of Defendants' Answering Joint Claim Construction Brief filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 05/17/2024) (2) |
| May 16, 2024 | 229 | STIPULATION TO EXTEND TIME the Deadline to Submit a Joint Letter regarding Claim Construction Hearing to July 11, 2024 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 05/16/2024) (3) |
| May 16, 2024 | N/A | SO ORDERED, D.I. 229 STIPULATION TO EXTEND TIME the Deadline to Submit a Joint Letter regarding Claim Construction Hearing to July 11, 2024 filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 05/16/2024. (smg) (Entered: 05/16/2024) (0) |
| May 10, 2024 | N/A | Notification regarding 221 USCA Notice of Docketing ROA, sent to Reporter Warner (mpb) (Entered: 05/10/2024) (0) |
| May 10, 2024 | N/A | Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 221 USCA Notice of Docketing ROA,. (mpb) (Entered: 05/10/2024) (0) |
| May 10, 2024 | 228 | REDACTED VERSION of 222 Objections, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 05/10/2024) (16) |
| May 9, 2024 | 227 | Notice of Appeal* (1) |
| May 7, 2024 | 225 | NOTICE OF SERVICE of Zydus's Second Set of Requests for the Production of Documents and Things to Plaintiffs (No. 2) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 05/07/2024) (2) |
| May 7, 2024 | 226 | NOTICE OF SERVICE of Defendants' Joint Interrogatories to Plaintiffs (Nos. 4-5) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 05/07/2024) (2) |
| May 6, 2024 | 223 | ORDER: Plaintiff's Objections, D.I. 222 , are denied. (See Order for further details.) Signed by Judge Joseph F. Bataillon on 05/06/2024. (vfm) (Entered: 05/06/2024) (1) |
| May 6, 2024 | 224 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Second Set of Requests for Production of Documents and Things (No. 2) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 05/06/2024) (2) |
| May 3, 2024 | 222 | [SEALED] OBJECTIONS by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. to 200 REPORT AND RECOMMENDATIONS re 98 MOTION for Preliminary Injunction filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc., 143 MOTION for Leave to File Reply Declarations of David . (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 05/03/2024) (0) |
| May 1, 2024 | 220 | REDACTED VERSION of 209 Reply Brief, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 05/01/2024) (17) |
| May 1, 2024 | 221 | NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 211 Notice of Appeal (Federal Circuit), filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. USCA Case Number 2024-1766 (jfm) (Entered: 05/01/2024) (4) |
| Apr 30, 2024 | 218 | Letter to the Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Request for Entry of Stipulated Proposed Order on Settlement and License Agreements. (Attachments: # 1 Text of Proposed Order)(Silver, Daniel) (Entered: 04/30/2024) (0) |
| Apr 30, 2024 | 219 | ORDER Regarding Production of Settlement and License Agreements. Signed by Judge Christopher J. Burke on 04/30/2024. (smg) (Entered: 04/30/2024) (2) |
| Apr 29, 2024 | 216 | REDACTED VERSION of 207 Answering Brief in Opposition, by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 04/29/2024) (22) |
| Apr 29, 2024 | 217 | REDACTED VERSION of 205 Letter, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 04/29/2024) (6) |
| Apr 26, 2024 | 212 | REDACTED VERSION of 201 Letter, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 04/26/2024) (3) |
| Apr 26, 2024 | 213 | REDACTED VERSION of 202 Declaration by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 04/26/2024) (10) |
| Apr 26, 2024 | 214 | REDACTED VERSION of 203 Emergency MOTION for Temporary Restraining Order by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 04/26/2024) (8) |
| Apr 26, 2024 | 215 | REDACTED VERSION of 204 Opening Brief in Support, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 04/26/2024) (30) |
| Apr 25, 2024 | 211 | NOTICE OF APPEAL to the Federal Circuit of 210 Order Adopting Report and Recommendations,, Terminate Motions,, Order on Motion for Preliminary Injunction,, Order on Report and Recommendations,, Order on Motion for TRO, . Appeal filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 04/25/2024) (2) |
| Apr 25, 2024 | N/A | APPEAL - Credit Card Payment received re 211 Notice of Appeal (Federal Circuit), filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. ( Filing fee $605, receipt number ADEDC-4392396.) (Silver, Daniel) (Entered: 04/25/2024) (0) |
| Apr 25, 2024 | N/A | Notification regarding 211 Notice of Appeal (Federal Circuit), sent to Reporter Warner (oam) (Entered: 04/25/2024) (0) |
| Apr 25, 2024 | N/A | Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 211 Notice of Appeal (Federal Circuit). (oam) (Entered: 04/25/2024) (0) |
| Apr 24, 2024 | 209 | [SEALED] REPLY BRIEF re 203 Emergency MOTION for Temporary Restraining Order filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 04/24/2024) (0) |
| Apr 24, 2024 | 210 | ORDER: The Court adopts the Magistrate Judge's Report and Recommendation in full, D.I. 200 , and accordingly denies Plaintiffs' Motion for Preliminary Injunction D.I. 98 . The Court denies Plaintiffs' Emergency Motion for Temporary Restraining Order, D.I. 203 . Signed by Judge Joseph F. Bataillon on 4/24/2024. (apk) (Entered: 04/24/2024) (3) |
| Apr 22, 2024 | 205 | [SEALED] Emergency Letter to The Honorable Joseph F. Bataillon and The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Astellas' Emergency Motion For Entry Of A Temporary Restraining Order - re 202 Declaration, 201 Letter, 203 Emergency MOTION for Temporary Restraining Order , 204 Opening Brief in Support,. (Attachments: # 1 Text of Proposed Order, # 2 Certificate of Service)(Silver, Daniel) (Entered: 04/22/2024) (0) |
| Apr 22, 2024 | 206 | Letter to The Honorable Joseph F. Bataillon and the Honorable Christopher J. Burke from Alexis N. Stombaugh regarding response to TRO motion - re 203 Emergency MOTION for Temporary Restraining Order , 205 Letter,. (Stombaugh, Alexis) (Entered: 04/22/2024) (1) |
| Apr 22, 2024 | 207 | [SEALED] ANSWERING BRIEF in Opposition re 203 Emergency MOTION for Temporary Restraining Order filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..Reply Brief due date per Local Rules is 4/29/2024. (Kraman, Pilar) (Entered: 04/22/2024) (0) |
| Apr 22, 2024 | 208 | DECLARATION re 207 Answering Brief in Opposition, of Pilar G. Kraman, by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Kraman, Pilar) (Entered: 04/22/2024) (0) |
| Apr 19, 2024 | 200 | [UNSEALED] REPORT AND RECOMMENDATIONS regarding D.I. 98 MOTION for Preliminary Injunction filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.,and D.I. 143 MOTION for Leave to File Reply Declarations of David R. Taft, Ph.D. and Steven R. Little, Ph.D. filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc.. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 5/3/2024. Signed by Judge Christopher J. Burke on 4/19/2024.This Recommendation will be emailed to local counsel. (dlb) Unsealed on 4/26/2024 after counsel advised of they do not intend to request redactions(smg). (Entered: 04/19/2024) (36) |
| Apr 19, 2024 | 201 | [SEALED] Letter to The Honorable Christopher J. Burke and The Honorable Joseph F. Bataillon from Daniel M. Silver, Esq. regarding Forthcoming Emergency Motion for Temporary Restraining Order. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 04/19/2024) (0) |
| Apr 19, 2024 | 202 | [SEALED] DECLARATION re 201 Letter, of Daniel M. Silver, Esq. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 04/19/2024) (0) |
| Apr 19, 2024 | 203 | [SEALED] Emergency MOTION for Temporary Restraining Order - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Rule 7.1.1. Certification, # 3 Certificate of Service)(Silver, Daniel) (Entered: 04/19/2024) (0) |
| Apr 19, 2024 | 204 | [SEALED] OPENING BRIEF in Support re 203 Emergency MOTION for Temporary Restraining Order filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..Answering Brief/Response due date per Local Rules is 5/3/2024. (Attachments: # 1 Exhibit 1, # 2 Certificate of Service)(Silver, Daniel) (Entered: 04/19/2024) (0) |
| Apr 18, 2024 | 199 | NOTICE OF SERVICE of (1) Astellas' Opening Claim Construction Brief and (2) Declaration of Vincent Li, Esq. with Exs. 1-20 filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 04/18/2024) (3) |
| Apr 15, 2024 | 198 | Official Transcript of Preliminary Injunction Hearing held on 3/19/24 before Judge Christopher J. Burke. Court Reporter Jennifer M. Guy,Email: jenniferguyrpr@gmail.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 5/6/2024. Redacted Transcript Deadline set for 5/16/2024. Release of Transcript Restriction set for 7/15/2024. (Triozzi, Heather) (Entered: 04/15/2024) (0) |
| Apr 4, 2024 | 196 | REDACTED VERSION of 151 Notice (Other) by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 04/04/2024) (30) |
| Apr 4, 2024 | 197 | REDACTED VERSION of 152 Notice (Other) by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 04/04/2024) (30) |
| Apr 3, 2024 | 195 | REDACTED VERSION of 188 Statement, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 04/03/2024) (13) |
| Apr 2, 2024 | 194 | ORAL ORDER: In addition to the referral in D.I. 186, the Court hereby ORDERS that Judge Burke is also referred Plaintiffs' Motion for Preliminary Injunction, (D.I. 98), for resolution. Ordered by Judge Joseph F. Bataillon on 4/2/2024. (dlb) (Entered: 04/02/2024) (0) |
| Apr 1, 2024 | 191 | Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Response - re 190 Letter. (Silver, Daniel) (Entered: 04/01/2024) (2) |
| Apr 1, 2024 | 192 | REDACTED VERSION of 156 Response to Motion by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 04/01/2024) (6) |
| Apr 1, 2024 | 193 | REDACTED VERSION of 158 Declaration of Jonathan B. Turpin by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit J - N)(Kraman, Pilar) (Entered: 04/01/2024) (0) |
| Mar 28, 2024 | 190 | Letter to The Honorable Christopher J. Burke from Pilar G. Kraman regarding Defendants' Objections to Plaintiffs' Lodged Transcripts - re 152 Notice (Other), 151 Notice (Other). (Kraman, Pilar) (Entered: 03/28/2024) (2) |
| Mar 27, 2024 | 187 | STIPULATION TO EXTEND TIME to submit public redacted versions of Plaintiffs' Notice of Lodging Volume 1 of 2 (D.I. 151) and Notice of Lodging Volume 2 of 2 (D.I. 152) to April 4, 2024 - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Stombaugh, Alexis) (Entered: 03/27/2024) (3) |
| Mar 27, 2024 | N/A | SO ORDERED D.I. 187 STIPULATION TO EXTEND TIME to submit public redacted versions of Plaintiffs' Notice of Lodging Volume 1 of 2 (D.I. 151) and Notice of Lodging Volume 2 of 2 (D.I. 152) to April 4, 2024 filed by Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Ordered by Judge Christopher J. Burke on 3/27/2024. (dlb) (Entered: 03/27/2024) (0) |
| Mar 27, 2024 | 188 | [SEALED] STATEMENT re 179 Oral Order,,,,,, Plaintiffs Astella's Supplemental Briefing on Infringement and Indefiniteness by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 03/27/2024) (0) |
| Mar 27, 2024 | 189 | Letter to The Honorable Christopher J. Burke from Defendants regarding Oral Order on Post-Hearing Briefing - re 179 Oral Order,,,,,,. (Kraman, Pilar) (Entered: 03/27/2024) (9) |
| Mar 26, 2024 | 185 | REDACTED VERSION of 176 Reply to Response to Motion, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/26/2024) (18) |
| Mar 26, 2024 | 186 | ORAL ORDER - Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 3/26/24. (AEV) (Entered: 03/26/2024) (0) |
| Mar 22, 2024 | N/A | SO ORDERED D.I. 184 STIPULATION TO EXTEND TIME for Defendants to submit redacted versions of Defendants Opposition to Astellass Motion for Leave to File Reply Declarations of David R. Taft, Ph.D. and Steven R. Little, Ph.D. (D.I. 156), and the Declaration of Jonathan B. filed by Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Ordered by Judge Christopher J. Burke on 3/22/2024. (dlb) (Entered: 03/22/2024) (0) |
| Mar 21, 2024 | 182 | STIPULATION TO EXTEND TIME the Deadline to Submit Public Redacted Versions of Plaintiffs' Notice of Lodging Volume 1 of 2 (D.I. 151) and Notice of Lodging Volume 2 of 2 (D.I. 152) to March 28, 2024 (from March 21, 2024) - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/21/2024) (3) |
| Mar 21, 2024 | 183 | NOTICE of Lodging by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (Attachments: # 1 Exhibit 1-4)(Joyce, Alexandra) (Entered: 03/21/2024) (0) |
| Mar 21, 2024 | N/A | SO ORDERED D.I. 182 STIPULATION TO EXTEND TIME the Deadline to Submit Public Redacted Versions of Plaintiffs' Notice of Lodging Volume 1 of 2 (D.I. 151) and Notice of Lodging Volume 2 of 2 (D.I. 152) to March 28, 2024 (from March 21, 2024) filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 3/21/2024. (dlb) (Entered: 03/21/2024) (0) |
| Mar 21, 2024 | 184 | STIPULATION TO EXTEND TIME for Defendants to submit redacted versions of Defendants Opposition to Astellass Motion for Leave to File Reply Declarations of David R. Taft, Ph.D. and Steven R. Little, Ph.D. (D.I. 156), and the Declaration of Jonathan B. Turpin, Esq. in Support of Defendants Opposition to Astellass Motion for Leave to File Reply Declarations of David R. Taft, Ph.D. and Steven R. Little, Ph.D. (D.I. 158) to April 1, 2024 - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Stombaugh, Alexis) (Entered: 03/21/2024) (2) |
| Mar 20, 2024 | 178 | ORAL ORDER: The Court, having reviewed Defendants' Motion to Determine Relatedness to C.A. 20-1589-JFB-CJB and Transfer of Case to Judge Bataillon ("Motion"), (D.I. 41), and the briefing related thereto, (D.I. 42; D.I. 59; D.I. 64), and having consulted with Judge Williams and Judge Bataillon, hereby ORDERS that the Motion is GRANTED and the case will be re-assigned to Judge Bataillon. The case is related to Judge Bataillon's prior matter (in Civil Action No. 20-1589-JFB-CJB) pursuant to the meaning of at least Local Rule 3.1(b)(2) and (4), for the reasons put forward by Defendants. And so re-assignment is appropriate. Ordered by Judge Christopher J. Burke on 3/20/2024. (dlb) (Entered: 03/20/2024) (0) |
| Mar 20, 2024 | N/A | Case Reassigned to Judge Joseph F. Bataillon of the United States District Court for the District of Nebraska (due to prior related case). Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) (Entered: 03/20/2024) (0) |
| Mar 20, 2024 | 179 | ORAL ORDER: As discussed at yesterday's preliminary injunction hearing, it would be helpful to the Court to have some further focused post-hearing briefing on some key issues now before it as to the pending preliminary injunction motion. To that end, the Court hereby ORDERS that by no later than March 27, 2024, both Plaintiffs and Defendants shall simultaneously each file with the Court a letter, not to exceed seven (7) single-spaced pages, in no less than 12-point font, further addressing the parties' arguments solely as to the issues of infringement and indefiniteness (and the related issue of claim construction, if appropriate), which in the Court's mind are the most difficult of the disputed issues at play here. It will be most helpful to the Court if in these filings, using language understandable to a lay person, the parties address what they believe are the key or best arguments in support of their position and explain why the other side's best arguments are nevertheless insufficient, while citing to the most important portions of the record or to the most important caselaw supporting their positions. Put differently, while the sides may have made many different arguments/citations in their briefing or their declarations about an infringement or definiteness issue, the Court is hoping here they will focus only on the most important arguments/citations and, using clear language, help the Court cut to the chase in terms of what it must address (and what it need not address) in order to resolve the issues. Ordered by Judge Christopher J. Burke on 3/20/2024. (dlb) (Entered: 03/20/2024) (0) |
| Mar 20, 2024 | 180 | [SEALED] NOTICE of Lodging by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Siew, Jennifer) (Entered: 03/20/2024) (0) |
| Mar 20, 2024 | 181 | REDACTED VERSION of 180 Notice (Other) of Lodging by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Siew, Jennifer) (Entered: 03/20/2024) (0) |
| Mar 19, 2024 | N/A | Minute Entry for proceedings held before Judge Christopher J. Burke - Hearing on Plaintiffs' Motion for Preliminary Injunction held on March 19, 2024. The Court heard the parties' arguments regarding Plaintiffs' Motion for Preliminary Injunction. (D.I. 98) The Court took the matter under advisement. (Clerk: A. Herman)Appearances: D. Silver, S. Roberts, J. Leonard and J. Guhaniyogi for Plaintiffs; M. Gaertner, D. Abramowitz, C. Blessing, J. Turpin, L. Brackensick, P. Kraman, A. Stombaugh, J. Siew, B. Zimmerman, A. Cheek, C. Pitzel Cruz and M. Haney for Defendants. (Court Reporter Jennifer Guy) (dlb) (Entered: 03/20/2024) (0) |
| Mar 18, 2024 | 176 | [SEALED] REPLY to Response to Motion re 143 MOTION for Leave to File Reply Declarations of David R. Taft, Ph.D. and Steven R. Little, Ph.D. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit O, # 2 Certificate of Service)(Silver, Daniel) (Entered: 03/18/2024) (0) |
| Mar 18, 2024 | 177 | Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Case Citation for March 19, 2024 Hearing. (Attachments: # 1 Enclosure - Liberty Ammunition, Inc. v. United States, 835 F.3d 1388, 1396-97 (Fed. Cir. 2016))(Silver, Daniel) (Entered: 03/18/2024) (0) |
| Mar 15, 2024 | 154 | REDACTED DOCUMENT re 100 Declaration,,, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 4, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 17, # 6 Exhibit 18, # 7 Exhibit 19, # 8 Exhibit 20, # 9 Exhibit 22, # 10 Exhibit 23, # 11 Exhibit 24, # 12 Exhibit 25, # 13 Exhibit 26, # 14 Exhibit 27, # 15 Exhibit 28, # 16 Exhibit 29, # 17 Exhibit 30, # 18 Exhibit 32, # 19 Exhibit 33, # 20 Exhibit 34, # 21 Exhibit 35, # 22 Exhibit 36, # 23 Exhibit 37, # 24 Exhibit 40, # 25 Exhibit 41, # 26 Exhibit 42, # 27 Exhibit 44, # 28 Exhibit 47, # 29 Exhibit 51, # 30 Exhibit 55, # 31 Exhibit 57, # 32 Exhibit 58, # 33 Exhibit 59, # 34 Exhibit 60, # 35 Exhibit 63, # 36 Exhibit 66, # 37 Exhibit 67, # 38 Exhibit 68, # 39 Exhibit 69)(Joyce, Alexandra) Modified on 3/15/2024 (smg). (Entered: 03/15/2024) (0) |
| Mar 15, 2024 | 156 | [SEALED] RESPONSE to Motion re 143 MOTION for Leave to File Reply Declarations of David R. Taft, Ph.D. and Steven R. Little, Ph.D. filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 03/15/2024) (0) |
| Mar 15, 2024 | 158 | [SEALED] DECLARATION re 156 Response to Motion -- of Jonathan B. Turpin, Esq. by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit J - N)(Kraman, Pilar) (Entered: 03/15/2024) (0) |
| Mar 15, 2024 | N/A | CORRECTING ENTRY: Docket entries 153, 155, 157 and 159 have been removed per request of counsel, to be refiled. (smg) (Entered: 03/15/2024) (0) |
| Mar 15, 2024 | 159 | REDACTED VERSION of 99 Opening Brief in Support, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/15/2024) (29) |
| Mar 15, 2024 | 160 | REDACTED VERSION of 102 Declaration, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/15/2024) (30) |
| Mar 15, 2024 | 161 | REDACTED VERSION of 103 Declaration, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/15/2024) (30) |
| Mar 15, 2024 | 162 | REDACTED VERSION of 104 Declaration, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/15/2024) (30) |
| Mar 15, 2024 | 163 | REDACTED VERSION of 105 Declaration, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/15/2024) (30) |
| Mar 15, 2024 | 164 | REDACTED VERSION of 106 Declaration, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/15/2024) (13) |
| Mar 15, 2024 | 165 | REDACTED VERSION of 141 Reply Brief by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/15/2024) (19) |
| Mar 15, 2024 | 166 | REDACTED VERSION of 142 Declaration, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/15/2024) (30) |
| Mar 15, 2024 | 167 | REDACTED VERSION of 143 MOTION for Leave to File Reply Declarations of David R. Taft, Ph.D. and Steven R. Little, Ph.D. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/15/2024) (16) |
| Mar 15, 2024 | 168 | REDACTED VERSION of 144 Declaration, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 03/15/2024) (30) |
| Mar 15, 2024 | 169 | REDACTED VERSION of 120 Answering Brief in Opposition, by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit A)(Kraman, Pilar) (Entered: 03/15/2024) (0) |
| Mar 15, 2024 | 170 | REDACTED VERSION of 121 Declaration of Walter Chambliss, Ph.D., by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 03/15/2024) (30) |
| Mar 15, 2024 | 171 | REDACTED VERSION of 122 Declaration of Ivan T. Hofmann by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 03/15/2024) (30) |
| Mar 15, 2024 | 172 | REDACTED VERSION of 123 Declaration Dr. John V. Kaspar by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 03/15/2024) (30) |
| Mar 15, 2024 | 173 | REDACTED VERSION of 124 Declaration of Radojka Savic, Ph.D. by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 03/15/2024) (30) |
| Mar 15, 2024 | 174 | REDACTED VERSION of 125 Declaration, of Jonathan B. Turpin, Esquire [Volume 1 of 2 (Exhibits 73 - 110)] by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit 73 - 79, # 2 Exhibit 80 - 90, # 3 Exhibit 91 - 100, # 4 Exhibit 101 - 110)(Kraman, Pilar) (Entered: 03/15/2024) (0) |
| Mar 15, 2024 | 175 | REDACTED VERSION of 126 Declaration, of Jonathan B. Turpin [Volume 2 of 2 (Exhibits 111 - 151)] by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit 111 - 124, # 2 Exhibit 125 - 140, # 3 Exhibit 141 - 151)(Kraman, Pilar) (Entered: 03/15/2024) (0) |
| Mar 14, 2024 | N/A | SO ORDERED D.I. 149 Unopposed MOTION for Exemption from the Standing Order Regarding Personal Electronic Devices filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc., and D.I. 146 MOTION Defendants' Motion for Exemption of Persons From the District of Delaware's May 15, 2023 Standing Order on Personal Devices filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Ordered by Judge Christopher J. Burke on 3/14/2024. (dlb) (Additional attachment(s) added on 3/14/2024: # 1 order) (dlb). (Entered: 03/14/2024) (0) |
| Mar 14, 2024 | 150 | ORAL ORDER: The Court, having reviewed the parties' March 12, 2024 letter, (D.I. 148), hereby ORDERS as follows: (1) With regard to the length of the hearing, each side will have 3.25 hours to present their case (inclusive of argument and direct/cross examination), with each side being able to use their allocated time as they see fit. We will take 15-minute breaks in the morning and afternoon, and have at least 30 minutes for lunch.; (2) With regard to the format of the hearing, the Court ADOPTS the parties' proposal.; (3) With regard to the issue of sealing the courtroom, the parties should be aware that Court does not expect to do so, absent a strong showing pursuant to applicable law that such sealing is warranted (and that there is no other less restrictive way to present the evidence or argument to the Court). If there are requests for sealing, the parties should make every effort to limit the number of discrete instances in which they seek to seal the courtroom.; (4) With regard to the disputed issue, the Court is not entirely sure it understands the dispute in light of the wording the parties have used in presenting their respective proposals. That said, the Court's view is that a party can rely on deposition testimony for any purpose during the hearing if the deposition testimony has already been submitted to the Court as part of the record on the ECF docket. In other words, the Court does not want have a situation where a party makes reference to a deposition transcript during the hearing (other than for impeachment purposes) and that transcript is not a part of the electronic case record on ECF, such that the Court would not be able to go back and review the transcript later by looking to the docket.; and (5) With regard to the parties' request to access the Courtroom for tech setup, they should contact the Court's Courtroom Deputy, Ms. Benyo to arrange this. Ordered by Judge Christopher J. Burke on 3/14/2024. (dlb) (Entered: 03/14/2024) (0) |
| Mar 14, 2024 | 151 | [SEALED] NOTICE of Lodging - Volume 1 of 2 by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (Attachments: # 1 Exhibit A&B, # 2 Certificate of Service)(Joyce, Alexandra) (Entered: 03/14/2024) (0) |
| Mar 14, 2024 | 152 | [SEALED] NOTICE of Lodging - Volume 2 of 2 by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (Attachments: # 1 Exhibit C & D, # 2 Certificate of Service)(Joyce, Alexandra) (Entered: 03/14/2024) (0) |
| Mar 13, 2024 | 149 | Unopposed MOTION for Exemption from the Standing Order Regarding Personal Electronic Devices - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Text of Proposed Order)Motions referred to Christopher J. Burke.(Joyce, Alexandra) (Entered: 03/13/2024) (0) |
| Mar 12, 2024 | 146 | MOTION Defendants' Motion for Exemption of Persons From the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order)Motions referred to Christopher J. Burke.(Haney, Megan) (Entered: 03/12/2024) (0) |
| Mar 12, 2024 | 147 | ORAL ORDER: Courtroom 2A is currently being used by a visiting Judge for a trial that will go through the week of March 18. In light of this, the Court hereby ORDERS that the preliminary injunction hearing scheduled for March 19, 2024 at 9:00 a.m. before Judge Christopher J. Burke will be held in Courtroom 2B. Ordered by Judge Christopher J. Burke on 3/12/2024. (dlb) (Entered: 03/12/2024) (0) |
| Mar 12, 2024 | 148 | Joint Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding preliminary injunction hearing. (Silver, Daniel) (Entered: 03/12/2024) (3) |
| Mar 8, 2024 | 145 | ORAL ORDER: The Court, having reviewed Plaintiffs' Motion for Leave to File Reply Declarations ("Motion"), (D.I. 143), hereby ORDERS that by no later than March 15, 2024, Defendants shall file an answering brief in opposition to the Motion of no more than four (4) single-spaced pages in no less than 12-point font. By no later than March 22, 2024, Plaintiffs shall file a reply letter brief of no more than two (2) single-spaced pages in no less than 12-point font. Ordered by Judge Christopher J. Burke on 3/8/2024. (dlb) (Entered: 03/08/2024) (0) |
| Mar 6, 2024 | 141 | [SEALED] REPLY BRIEF re 98 MOTION for Preliminary Injunction filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 03/06/2024) (0) |
| Mar 6, 2024 | 142 | [SEALED] DECLARATION re 141 Reply Brief of Vincent Li, Esq. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit 152, # 2 Exhibit 153-160, # 3 Exhibit 161-167, # 4 Certificate of Service)(Silver, Daniel) (Entered: 03/06/2024) (0) |
| Mar 6, 2024 | 143 | [SEALED] MOTION for Leave to File Reply Declarations of David R. Taft, Ph.D. and Steven R. Little, Ph.D. - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Rule 7.1.1. Certification, # 3 Certificate of Service)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 03/06/2024) (0) |
| Mar 6, 2024 | 144 | [SEALED] DECLARATION re 143 MOTION for Leave to File Reply Declarations of David R. Taft, Ph.D. and Steven R. Little, Ph.D. of Vincent Li, Esq. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit A-I Pt. 1, # 2 Exhibit A-I Pt. 2, # 3 Certificate of Service)(Silver, Daniel) (Entered: 03/06/2024) (0) |
| Feb 28, 2024 | 140 | STIPULATION TO EXTEND TIME for the parties to submit redacted briefing for Plaintiffs' Motion for Preliminary Injunction to March 15, 2024 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Haney, Megan) (Entered: 02/28/2024) (2) |
| Feb 28, 2024 | N/A | SO ORDERED D.I. 140 STIPULATION TO EXTEND TIME for the parties to submit redacted briefing for Plaintiffs' Motion for Preliminary Injunction to March 15, 2024 filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Due to the number of extensions granted, it is ORDERED that any further requests of this nature will be denied absent good cause. Ordered by Judge Christopher J. Burke on 2/28/2024. (dlb) (Entered: 02/28/2024) (0) |
| Feb 23, 2024 | 139 | SO ORDERED D.I. 137 STIPULATION TO EXTEND TIME for Various Deadlines. Amended Scheduling Order Deadlines: Claim Construction Opening Brief due by 4/18/2024., Amended Pleadings due by 7/25/2024., Fact Discovery completed by 8/22/2024., Opening Expert Reports due by 10/2/2024., Rebuttal Expert Reports due by 11/6/2024., Expert Discovery due by 1/15/2025., Joinder of Parties due by 7/25/2024., A Markman Hearing is set for 8/21/2024 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke. Please see Stipulation for further details and deadlines. Signed by Judge Christopher J. Burke on 2/22/2024. (dlb) (Entered: 02/23/2024) (4) |
| Feb 22, 2024 | 138 | Amended NOTICE of Deposition of Walter Chambliss, Ph.D. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (Joyce, Alexandra) (Entered: 02/22/2024) (2) |
| Feb 21, 2024 | 137 | STIPULATION TO EXTEND TIME for Various Deadlines to (see Stipulation for Details) - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 02/21/2024) (4) |
| Feb 16, 2024 | 134 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production (No. 1) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 02/16/2024) (2) |
| Feb 16, 2024 | 135 | STIPULATION TO EXTEND TIME for Defendants to submit public redacted versions of the Answering Brief in Opposition to Plaintiffs' Motion for Preliminary Injunction and Supporting Declarations to March 1, 2024 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Haney, Megan) (Entered: 02/16/2024) (2) |
| Feb 16, 2024 | N/A | SO ORDERED D.I. 135 STIPULATION TO EXTEND TIME for Defendants to submit public redacted versions of the Answering Brief in Opposition to Plaintiffs' Motion for Preliminary Injunction and Supporting Declarations to March 1, 2024 filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Ordered by Judge Christopher J. Burke on 2/16/2024. (mlc) (Entered: 02/16/2024) (0) |
| Feb 16, 2024 | 136 | NOTICE to Take Deposition of Radojka Savic, Ph.D. on February 20, 2024 at 9:00 am PST filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 02/16/2024) (2) |
| Feb 15, 2024 | 132 | NOTICE OF SERVICE of Defendants Zydus Pharmaceuticals (USA) Inc.'s, and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Second Set of Interrogatories to Zydus (No. 3). filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) (Entered: 02/15/2024) (2) |
| Feb 15, 2024 | 133 | NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Objections and Responses to Plaintiffs' Second Set of Interrogatories (No. 3) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 02/15/2024) (2) |
| Feb 14, 2024 | 127 | NOTICE to Take Deposition of Walter Chambliss, Ph.D. on February 26, 2024 filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 02/14/2024) (2) |
| Feb 14, 2024 | 128 | NOTICE to Take Deposition of Ivan T. Hofman on February 27, 2024 filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 02/14/2024) (2) |
| Feb 14, 2024 | 129 | NOTICE to Take Deposition of Dr. John V. Kaspar on February 23, 2024 filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 02/14/2024) (2) |
| Feb 14, 2024 | 130 | NOTICE to Take Deposition of Radojka Savic, Ph.D. on February 20, 2024 filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 02/14/2024) (2) |
| Feb 14, 2024 | 131 | Amended NOTICE of Deposition of Ivan T. Hofmann by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (Joyce, Alexandra) (Entered: 02/14/2024) (2) |
| Feb 13, 2024 | 120 | [SEALED] ANSWERING BRIEF in Opposition re 98 MOTION for Preliminary Injunction filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..Reply Brief due date per Local Rules is 2/20/2024. (Attachments: # 1 Exhibit A)(Kraman, Pilar) (Entered: 02/13/2024) (0) |
| Feb 13, 2024 | 121 | [SEALED] DECLARATION re 120 Answering Brief in Opposition, of Walter Chambliss, Ph.D., by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 02/13/2024) (0) |
| Feb 13, 2024 | 122 | [SEALED] DECLARATION re 120 Answering Brief in Opposition, of Ivan T. Hoffman by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 02/13/2024) (0) |
| Feb 13, 2024 | 123 | [SEALED] DECLARATION re 120 Answering Brief in Opposition, of Dr. John V. Kaspar, by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 02/13/2024) (0) |
| Feb 13, 2024 | 124 | [SEALED] DECLARATION re 120 Answering Brief in Opposition, of Radojka Savic, Ph.D., by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 02/13/2024) (0) |
| Feb 13, 2024 | 125 | [SEALED] DECLARATION re 120 Answering Brief in Opposition, of Jonathan B. Turpin, Esquire [Volume 1 of 2 (Exhibits 73 - 110)] by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit 73 - 79, # 2 Exhibit 80 - 90, # 3 Exhibit 91 - 100, # 4 Exhibit 101 - 110)(Kraman, Pilar) (Entered: 02/13/2024) (0) |
| Feb 13, 2024 | 126 | [SEALED] DECLARATION re 120 Answering Brief in Opposition, of Jonathan B. Turpin [Volume 2 of 2 (Exhibits 111 - 151)] by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit 111 - 124, # 2 Exhibit 125 - 140, # 3 Exhibit 141 - 151)(Kraman, Pilar) (Entered: 02/13/2024) (0) |
| Feb 9, 2024 | 119 | STIPULATION TO EXTEND TIME for Plaintiffs to submit public redacted versions of the Opening Brief and Supporting Declarations regarding Plaintiffs' Motion for Preliminary Injunction (D.I. 99, 100, 102, 103, 104, 105 and 106) to February 16, 2024 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Haney, Megan) (Entered: 02/09/2024) (2) |
| Feb 9, 2024 | N/A | SO ORDERED D.I. 119 STIPULATION TO EXTEND TIME for Plaintiffs to submit public redacted versions of the Opening Brief and Supporting Declarations regarding Plaintiffs' Motion for Preliminary Injunction (D.I. 99, 100, 102, 103, 104, 105 and 106) to February 16, 2024 filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Ordered by Judge Christopher J. Burke on 2/9/2024. (dlb) (Entered: 02/09/2024) (0) |
| Feb 2, 2024 | 118 | STIPULATION TO EXTEND TIME the deadline for Plaintiffs to submit public redacted versions of the Opening Brief and Supporting Declarations regarding Plaintiffs' Motion for Preliminary Injunction (D.I. 99, 100, 102, 103, 104, 105, and 106) to February 9, 2024 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 02/02/2024) (2) |
| Feb 2, 2024 | N/A | SO ORDERED D.I. 118 STIPULATION TO EXTEND TIME the deadline for Plaintiffs to submit public redacted versions of the Opening Brief and Supporting Declarations regarding Plaintiffs' Motion for Preliminary Injunction (D.I. 99, 100, 102, 103, 104, 105, and 106) to Febr filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 2/2/2024. (dlb) (Entered: 02/02/2024) (0) |
| Feb 1, 2024 | 112 | NOTICE to Take Deposition of Dr. Steven R. Little on February 8, 2024 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 02/01/2024) (3) |
| Feb 1, 2024 | 113 | NOTICE to Take Deposition of Dr. David R. Taft on February 1, 2024 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 02/01/2024) (3) |
| Feb 1, 2024 | 114 | NOTICE to Take Deposition of Dr. Christopher A. Vellturo on February 1, 2024 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 02/01/2024) (3) |
| Feb 1, 2024 | 115 | NOTICE to Take Deposition of Mark Schwitzenberg on February 2, 2024 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 02/01/2024) (3) |
| Feb 1, 2024 | 116 | NOTICE to Take Deposition of Dr. Victor W. Nitti on January 31, 2024 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) (Entered: 02/01/2024) (3) |
| Feb 1, 2024 | 117 | ORAL ORDER: The Court has reviewed the parties' motions for claim construction, (D.I. 110; D.I. 111), which were filed in conformance with the current Scheduling Order's requirements. The Court notes that since the Scheduling Order was entered in this case, (D.I. 50), it has changed its policies regarding when parties must file their motions for claim construction; the Court now requires parties to file those motions concurrently with the filing of the Joint Claim Construction Brief. See paragraph 13 of Judge Burke's "Rule 16 Scheduling OrderPatent" found on Judge Burke's portion of the District Court's website. In light of this, the Court hereby ORDERS that the parties shall re-file their motions for claim construction concurrently with the filing of the Joint Claim Construction Brief. Ordered by Judge Christopher J. Burke on 2/1/2024. (dlb) (Entered: 02/01/2024) (0) |
| Jan 31, 2024 | 108 | CLAIM Construction Chart by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 01/31/2024) (5) |
| Jan 31, 2024 | 109 | Joint APPENDIX re 108 Claim Construction Chart by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Silver, Daniel) (Entered: 01/31/2024) (0) |
| Jan 31, 2024 | 110 | Joint MOTION for Claim Construction re 108 Claim Construction Chart - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. Motions referred to Christopher J. Burke.(Stombaugh, Alexis) (Entered: 01/31/2024) (2) |
| Jan 31, 2024 | 111 | MOTION for Claim Construction re 108 Claim Construction Chart - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Text of Proposed Order)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 01/31/2024) (0) |
| Jan 29, 2024 | N/A | CORRECTING ENTRY: Declaration Filed at D.I. 104 on 1/26/2024 was replaced with the corrected confidentiality stamp, per Counsel's request. (jfm) (Entered: 01/29/2024) (0) |
| Jan 29, 2024 | 107 | STATEMENT re 103 Declaration, Errata to the Declaration of David R. Taft, Ph.D. In Support of Plaintiffs' Motion for Preliminary Injunction by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 01/29/2024) (1) |
| Jan 26, 2024 | 98 | MOTION for Preliminary Injunction - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Proposed Order, # 2 Rule 7.1.1 Certification)Motions referred to Christopher J. Burke.(Silver, Daniel) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 99 | [SEALED] OPENING BRIEF in Support re 98 MOTION for Preliminary Injunction filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..Answering Brief/Response due date per Local Rules is 2/9/2024. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 100 | [SEALED] DECLARATION re 99 Opening Brief in Support, 98 MOTION for Preliminary Injunction Declaration of Vincent Li [VOLUME 1 - CONFIDENTIAL EXHIBITS] by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Ex. 2, # 2 Ex. 4, # 3 Ex. 11, # 4 Ex. 12, # 5 Ex. 17, # 6 Ex. 18, # 7 Ex. 19, # 8 Ex. 20, # 9 Ex. 22, # 10 Ex. 23, # 11 Ex. 24, # 12 Ex. 25, # 13 Ex. 26, # 14 Ex. 27, # 15 Ex. 28, # 16 Ex. 29, # 17 Ex. 30, # 18 Ex. 32, # 19 Ex. 33, # 20 Ex. 34, # 21 Ex. 35, # 22 Ex. 36, # 23 Ex. 37, # 24 Ex. 40, # 25 Ex. 41, # 26 Ex. 42, # 27 Ex. 43, # 28 Ex. 44, # 29 Ex. 47, # 30 Ex. 51, # 31 Ex. 55, # 32 Ex. 57, # 33 Ex. 58, # 34 Ex. 59, # 35 Ex. 60, # 36 Ex. 63, # 37 Ex. 66, # 38 Ex. 67, # 39 Ex. 68, # 40 Ex. 69, # 41 Certificate of Service)(Silver, Daniel) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 101 | DECLARATION re 99 Opening Brief in Support, 98 MOTION for Preliminary Injunction , 100 Declaration,,, Declaration of Vincent Li [VOLUME 2 - Non Confidential Exhibits] by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Ex. 1, # 2 Ex. 3, # 3 Ex. 5, # 4 Ex. 6, # 5 Ex. 7, # 6 Ex. 8, # 7 Ex. 9, # 8 Ex. 10, # 9 Ex. 13, # 10 Ex. 14, # 11 Ex. 15, # 12 Ex. 16, # 13 Ex. 21, # 14 Ex. 31, # 15 Ex. 38, # 16 Ex. 39, # 17 Ex. 45, # 18 Ex. 46, # 19 Ex. 48, # 20 Ex. 49, # 21 Ex. 50, # 22 Ex. 52, # 23 Ex. 53, # 24 Ex. 54, # 25 Ex. 56, # 26 Ex. 61, # 27 Ex. 62, # 28 Ex. 64, # 29 Ex. 65, # 30 Ex. 70, # 31 Ex. 71, # 32 Ex. 72)(Silver, Daniel) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 102 | [SEALED] DECLARATION re 98 MOTION for Preliminary Injunction , 99 Opening Brief in Support, Declaration of Victor W. Nitti, MD by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 103 | [SEALED] DECLARATION re 98 MOTION for Preliminary Injunction , 99 Opening Brief in Support, Declaration of David R. Taft, Ph.D. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 104 | [SEALED] DECLARATION re 98 MOTION for Preliminary Injunction , 99 Opening Brief in Support, Declaration of Steven R. Little, Ph.D. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Main Document 104 replaced on 1/29/2024) (jfm). (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 105 | [SEALED] DECLARATION re 98 MOTION for Preliminary Injunction , 99 Opening Brief in Support, Declaration of Christopher A. Vellturo, Ph.D. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 01/26/2024) (0) |
| Jan 26, 2024 | 106 | [SEALED] DECLARATION re 98 MOTION for Preliminary Injunction , 99 Opening Brief in Support, Declaration of Mark Schwitzenberg by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 01/26/2024) (0) |
| Jan 24, 2024 | 97 | NOTICE requesting Clerk to remove Rodney Swartz as co-counsel.. (Joyce, Alexandra) (Entered: 01/24/2024) (2) |
| Jan 23, 2024 | N/A | SO ORDERED D.I. 96 STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit the Joint Claim Construction Chart to January 31, 2024 filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 1/23/2024. (dlb) (Entered: 01/23/2024) (0) |
| Jan 22, 2024 | 94 | SO ORDERED D.I. 92 Stipulation filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. See Stipulation for deadlines and further details.. Signed by Judge Christopher J. Burke on 1/19/2024. (dlb) (Entered: 01/22/2024) (4) |
| Jan 22, 2024 | 95 | ORAL ORDER: The preliminary injunction hearing will be held before Judge Burke in Courtroom 2A on March 19, 2024 beginning at 9:00 a.m. By no later than March 12, 2024, the parties shall advise the Court how much time they believe should be allocated for the hearing, and of the identities of the witnesses appearing live or by deposition at the hearing and the order of those witnesses. Ordered by Judge Christopher J. Burke on 1/22/2024. (dlb) (Entered: 01/22/2024) (0) |
| Jan 22, 2024 | N/A | SO ORDERED D.I. 93 Stipulation regarding Prior Discovery filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 1/22/2024. (dlb) (Entered: 01/22/2024) (0) |
| Jan 22, 2024 | 96 | STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit the Joint Claim Construction Chart to January 31, 2024 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 01/22/2024) (2) |
| Jan 19, 2024 | 93 | STIPULATION and [Proposed] Oder regarding Prior Discovery by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 01/19/2024) (4) |
| Jan 18, 2024 | 92 | STIPULATION and [Proposed] Order Regarding Preliminary Injunction Proceedings by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 01/18/2024) (4) |
| Jan 17, 2024 | 91 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production of Documents and Things (No. 1) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 01/17/2024) (2) |
| Jan 16, 2024 | N/A | SO ORDERED D.I. 81 MOTION for Pro Hac Vice Appearance of Attorney Jacob Michael Bass filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 1/16/24. (dlb) (Entered: 01/16/2024) (0) |
| Jan 16, 2024 | 90 | NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories to Defendants filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 01/16/2024) (3) |
| Jan 12, 2024 | N/A | SO ORDERED D.I. 84 STIPULATION TO EXTEND TIME to exchange lists of claim terms/phrases that need construction and proposed claim construction to January 12, 2024 filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 1/11/2024. (dlb) (Entered: 01/12/2024) (0) |
| Jan 12, 2024 | 85 | REDACTED VERSION of 79 Letter, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 01/12/2024) (30) |
| Jan 12, 2024 | 86 | NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Notice Pursuant to D.I. 83 and D.I. 77-1 filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 01/12/2024) (2) |
| Jan 12, 2024 | 87 | NOTICE OF SERVICE of Plaintiffs' List of Claim Terms and Proposed Claim Constructions filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 01/12/2024) (3) |
| Jan 12, 2024 | 88 | NOTICE OF SERVICE of Defendants' Disclosure of Claim Terms and Constructions filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 01/12/2024) (2) |
| Jan 12, 2024 | 89 | NOTICE OF SERVICE of Defendants Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited's Notice Pursuant to D.I. 83 and D.I. 77-1 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 01/12/2024) (2) |
| Jan 11, 2024 | 84 | STIPULATION TO EXTEND TIME to exchange lists of claim terms/phrases that need construction and proposed claim construction to January 12, 2024 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 01/11/2024) (2) |
| Jan 10, 2024 | 81 | MOTION for Pro Hac Vice Appearance of Attorney Jacob Michael Bass - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certification for Jacob Michael Bass)Motions referred to Christopher J. Burke.(Joyce, Alexandra) (Entered: 01/10/2024) (0) |
| Jan 10, 2024 | 82 | Pro Hac Vice Fee - Credit Card Payment received for Jacob Michael Bass. ( re 81 MOTION for Pro Hac Vice Appearance of Attorney Jacob Michael Bass )( Payment of $ 50, receipt number ADEDC-4311087).(Joyce, Alexandra) (Entered: 01/10/2024) (0) |
| Jan 10, 2024 | 83 | ORAL ORDER: The Court has reviewed the parties' pending discovery dispute motion ("Motion"), (D.I. 73), in which they take different positions about how to manage a potential preliminary injunction process in this case. The parties discussed that issue with the Court during an October 23, 2023 Case Management Conference, (D.I. 39), and then further presented their positions and the reasons for them in a December 15, 2023 Interim Status Report, (D.I. 71), and again in supplemental letter briefs, (D.I. 77; D.I. 79). In light of that, the Court has more than enough information about the parties' views to make a decision, and therefore today's scheduled videoconference, (D.I. 75), is CANCELED. With regard to the Motion, the Court ADOPTS Defendants' proposal. (D.I. 77-1) Although ANDA litigation is unique in some ways as compared to other forms of civil litigation (including other types of patent litigation), the Court generally tries to treat ANDA cases just as it would other civil matters. And in the main, courts rely on a plaintiff who intends to file a preliminary injunction motion ("PI Motion") to gather, on its own, whatever evidence it believes supports such a motion, prior to filing that motion with the court. That is because courts are not usually in the business of ordering parties to produce information relating to an issue that is not yet part of a case, or relating to a motion that has not yet been filed in a case (and may never be filed). Defendants' proposal here--by which they will provide notice as of a certain date of whether they will agree not to launch their ANDA products until a final trial decision in this matter--is less invasive than Plaintiffs' proposal and better aligns with this typical approach. It is also the path that another Judge of this Court followed in Novartis v. Accord Healthcare Inc., No. 18-1043-LPS (D. Del. Oct. 25, 2018) (cited in D.I. 77, ex. 1), and it is generally in accord with a number of other judicial decisions on this issue, (see D.I. 77 at 2). Ordered by Judge Christopher J. Burke on 1/10/2024. (dlb) (Entered: 01/10/2024) (0) |
| Jan 8, 2024 | 80 | NOTICE OF SERVICE of Defendants' Joint Invalidity Contentions filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 01/08/2024) (2) |
| Jan 5, 2024 | 78 | REDACTED VERSION of 77 Letter, by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit 1 - 6)(Kraman, Pilar) (Entered: 01/05/2024) (0) |
| Jan 5, 2024 | 79 | [SEALED] Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Response to Defendants' Letter regarding Preliminary Injunction Scheduling & Discovery Disputes. (Attachments: # 1 Exhibit A-M, # 2 Certificate of Service)(Silver, Daniel) (Entered: 01/05/2024) (0) |
| Dec 29, 2023 | 77 | [SEALED] Letter to The Honorable Christopher J. Burke from Pilar G. Kraman regarding Preliminary Injunction Scheduling & Discovery Disputes - re 75 Order Setting Teleconference,,,,,,. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Kraman, Pilar) (Entered: 12/29/2023) (0) |
| Dec 26, 2023 | N/A | SO ORDERED, re 74 Stipulation of Dismissal as to Sandoz Inc. Sandoz Inc. terminated. Attorney Elizabeth A. DeFelice; Dominick T. Gattuso; Greg L. Goldblatt; William A. Rakoczy; Rachel P. Waldron; Steven J. Birkos and Kevin P. Burke terminated. Signed by Judge Gregory B. Williams on 12/22/23. (ntl) (Entered: 12/26/2023) (0) |
| Dec 22, 2023 | 76 | REDACTED VERSION of 71 Status Report by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 12/22/2023) (4) |
| Dec 21, 2023 | 74 | STIPULATION of Dismissal with Prejudice by Sandoz Inc.. (Gattuso, Dominick) (Entered: 12/21/2023) (2) |
| Dec 21, 2023 | 75 | ORAL ORDER Setting Videoconference: The Court, having reviewed the parties' interim status report, (D.I. 71), hereby ORDERS as follows: (1) A discovery dispute videoconference using the Microsoft Teams platform is set for January 10, 2024 at 3:00 p.m. before Judge Christopher J. Burke.; (2) By December 29, 2023, Defendants shall file with the Court a letter, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining the issues in dispute and their position on those issues. By no later than January 5, 2024, Plaintiffs shall file with the Court a letter, not to exceed two (2) single-spaced pages, in no less than 12-point font, outlining the reasons for their opposition.; (3) By no later than January 5, 2024, the parties shall send an e-mail to the Court's Courtroom Deputy, Ms. Benyo, indicating the names and e-mail addresses of all individuals who will participate in the videoconference.; (4) The parties should also consult and follow Judge Burke's "Guidelines for Discovery Disputes," which is found in the "Guidelines" tab on Judge Burke's portion of the District Court's website.; and (5) The Court may choose to resolve the dispute prior to the videoconference and will, in that event, cancel the videoconference (however, if any party advises the Court in advance that a newer attorney will argue the dispute, see Standing Order Regarding Courtroom Opportunities for Newer Attorneys, https://www.ded.uscourts.gov/sites/ded/files/StandingOrder2017.pdf, then the Court will go forward with the conference). Ordered by Judge Christopher J. Burke on 12/21/2023. (dlb) (Entered: 12/21/2023) (0) |
| Dec 20, 2023 | 72 | Letter to The Honorable Christopher J. Burke from Pilar G. Kraman regarding request for discovery teleconference. (Kraman, Pilar) (Entered: 12/20/2023) (2) |
| Dec 20, 2023 | 73 | MOTION for Teleconference to Resolve Discovery Dispute re 72 Letter - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. Motions referred to Christopher J. Burke.(Kraman, Pilar) (Entered: 12/20/2023) (3) |
| Dec 15, 2023 | 71 | [SEALED] Interim STATUS REPORT by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 12/15/2023) (0) |
| Dec 11, 2023 | 68 | NOTICE OF SERVICE of 1) Defendants Zydus Pharmaceuticals (USA) Inc.'s and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Interrogatories to Zydus (Nos. 1-2); and 2) Defendants Zydus Pharmaceuticals (USA) Inc.'s and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1 - 2). filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 12/11/2023) (2) |
| Dec 11, 2023 | 69 | REQUEST for Oral Argument by Lupin Ltd., Lupin Pharmaceuticals, Inc. re 41 MOTION Defendants' Motion to Determine Relatedness to C.A. No. 20-1589-JFB-CJB and Transfer of Case to Judge Bataillon . (Phillips, John) (Entered: 12/11/2023) (1) |
| Dec 11, 2023 | 70 | NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Objections and Responses to Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-2) and Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-2) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 12/11/2023) (2) |
| Dec 7, 2023 | 67 | STIPULATION TO EXTEND TIME for the parties to file a joint interim status report to December 15, 2023 - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Stombaugh, Alexis) (Entered: 12/07/2023) (2) |
| Dec 7, 2023 | N/A | SO ORDERED D.I. 67 STIPULATION TO EXTEND TIME for the parties to file a joint interim status report to December 15, 2023 filed by Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Ordered by Judge Christopher J. Burke on 12/7/2023. (dlb) (Entered: 12/07/2023) (0) |
| Dec 5, 2023 | N/A | SO ORDERED D.I. 66 Second STIPULATION TO EXTEND TIME for Sandoz to serve its Rule 26(a)(1) Initial Disclosures, E-Discovery Default Standard Disclosures, and Default Standard 4(b) Disclosures to December 21, 2023 filed by Sandoz Inc. Ordered by Judge Christopher J. Burke on 12/5/2023. (dlb) (Entered: 12/05/2023) (0) |
| Dec 4, 2023 | 64 | REPLY BRIEF re 41 MOTION Defendants' Motion to Determine Relatedness to C.A. No. 20-1589-JFB-CJB and Transfer of Case to Judge Bataillon filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) (Entered: 12/04/2023) (11) |
| Dec 4, 2023 | 65 | DECLARATION re 64 Reply Brief of Andrea Cheek by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 5, # 2 Exhibit 6, # 3 Exhibit 7, # 4 Exhibit 8, # 5 Exhibit 9, # 6 Exhibit 10)(Phillips, John) (Entered: 12/04/2023) (0) |
| Dec 4, 2023 | 66 | Second STIPULATION TO EXTEND TIME for Sandoz to serve its Rule 26(a)(1) Initial Disclosures, E-Discovery Default Standard Disclosures, and Default Standard 4(b) Disclosures to December 21, 2023 - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 12/04/2023) (2) |
| Nov 28, 2023 | 63 | NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 7(b) of the Scheduling Order and Production of Core Technical Documents filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 11/28/2023) (2) |
| Nov 27, 2023 | 61 | NOTICE OF SERVICE of Plaintiffs' Initial Disclosures Identifying Defendants' Accused Products and Plaintiffs' Asserted Patent filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 11/27/2023) (4) |
| Nov 27, 2023 | 62 | NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited's Core Technical Documents bearing Bates Numbers ZYDMYB0173729 ZYDMYB0175944. filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 11/27/2023) (2) |
| Nov 22, 2023 | 60 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contention Charts filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Silver, Daniel) (Entered: 11/22/2023) (4) |
| Nov 20, 2023 | 58 | NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 11/20/2023) (2) |
| Nov 20, 2023 | 59 | ANSWERING BRIEF in Opposition re 41 MOTION Defendants' Motion to Determine Relatedness to C.A. No. 20-1589-JFB-CJB and Transfer of Case to Judge Bataillon filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..Reply Brief due date per Local Rules is 11/27/2023. (Attachments: # 1 Exhibit A-C)(Silver, Daniel) (Entered: 11/20/2023) (0) |
| Nov 17, 2023 | 57 | NOTICE OF SERVICE of 1) Defendants Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited's Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery; and 2) Defendants Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited's Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 11/17/2023) (2) |
| Nov 16, 2023 | 54 | STIPULATION TO EXTEND TIME for Sandoz to serve its Rule 26(a)(1) Initial Disclosures, E-Discovery Default Standard Disclosures, and Default Standard 4(b) Disclosures to December 7, 2023 - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 11/16/2023) (2) |
| Nov 16, 2023 | N/A | SO ORDERED D.I. 54 STIPULATION TO EXTEND TIME for Sandoz to serve its Rule 26(a)(1) Initial Disclosures, E-Discovery Default Standard Disclosures, and Default Standard 4(b) Disclosures to December 7, 2023 filed by Sandoz Inc. Ordered by Judge Christopher J. Burke on 11/16/2023. (dlb) (Entered: 11/16/2023) (0) |
| Nov 16, 2023 | 55 | NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Paragraph 3 of the Court's Default Standard for Discovery; and (2) Plaintiffs' Rule 26(a)(1) Initial Disclosures for Litigation Involving U.S. Patent No. 11,707,451 filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 11/16/2023) (4) |
| Nov 16, 2023 | 56 | NOTICE OF SERVICE of Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 11/16/2023) (2) |
| Nov 13, 2023 | N/A | SO ORDERED D.I. 51 STIPULATION TO EXTEND TIME the Parties Deadline for Briefing regarding Defendants Motion to Determine Relatedness to C.A. No. 20-1589-JFB and Transfer of Case to Judge Bataillon to November 20, 2023 & December 4, 2023 filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 11/13/2023. (dlb) (Entered: 11/13/2023) (0) |
| Nov 13, 2023 | 53 | STIPULATION TO EXTEND TIME (1) Plaintiffs to serve their Infringement Contentions and (2) Defendants to serve their Invalidity Contentions to See Stip for Details - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 11/13/2023) (2) |
| Nov 13, 2023 | N/A | SO ORDERED D.I. 53 STIPULATION TO EXTEND TIME (1) Plaintiffs to serve their Infringement Contentions and (2) Defendants to serve their Invalidity Contentions to See Stip for Details filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 11/13/2023. (dlb) (Entered: 11/13/2023) (0) |
| Nov 10, 2023 | 52 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories to Defendants (Nos. 1-2); and (2) Plaintiffs' First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-2) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 11/10/2023) (4) |
| Nov 9, 2023 | 51 | STIPULATION TO EXTEND TIME the Parties Deadline for Briefing regarding Defendants Motion to Determine Relatedness to C.A. No. 20-1589-JFB and Transfer of Case to Judge Bataillon to November 20, 2023 & December 4, 2023 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 11/09/2023) (2) |
| Nov 8, 2023 | 49 | PROPOSED ORDER [Corrected] Patent Case Scheduling Order by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) (Entered: 11/08/2023) (18) |
| Nov 8, 2023 | 50 | Amended SCHEDULING ORDER: Joinder of Parties due by 05/30/2024. Amended Pleadings due by 05/30/2024. Discovery due by 6/28/2024. Opening Expert Reports due by 8/8/2024. Rebuttal Expert Reports due by 9/12/2024. Reply Expert Reports due by 10/10/2024. Expert Discovery due by 11/22/2024. Status Report due by 12/8/2023. Claim Construction Opening Brief due by 2/22/2024. Claim Construction Answering Brief due by 3/21/2024. Claim Construction Reply Brief due by 4/18/2024. Claim Construction Surreply Brief due by 5/9/2024. Joint Claim Construction Brief due by 5/16/2024. A Markman Hearing is set for 5/29/2024 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke. A Pretrial Conference is set for 9/4/2025 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A 5-day Bench Trial is set for 9/8/2025 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams.. Signed by Judge Christopher J. Burke on 11/8/2023. (dlb) Modified on 11/13/2023 (dlb). (Entered: 11/08/2023) (16) |
| Nov 6, 2023 | 48 | NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' Joint First Set of Interrogatories (Nos. 1-3), (2) Plaintiffs' Objections and Responses to Defendants' Joint First Set of Requests for Production (Nos. 1-10), (3) Plaintiffs' Objections and Responses to Zydus's First Set of Requests for Production (No. 1), and (4) Plaintiffs' Objections and Responses to Zydus's First Set of Interrogatories (No. 1) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 11/06/2023) (4) |
| Nov 3, 2023 | 46 | PROPOSED ORDER Protective Order by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 11/03/2023) (30) |
| Nov 3, 2023 | 47 | Stipulated PROTECTIVE ORDER. Signed by Judge Christopher J. Burke on 11/3/2023. (dlb) (Entered: 11/03/2023) (30) |
| Nov 2, 2023 | 45 | SCHEDULING ORDER: Joinder of Parties due by 5/30/2024. Amended Pleadings due by 5/30/2024. Discovery due by 6/30/2024. Opening Expert Reports due by 8/8/2024. Rebuttal Expert Reports due by 9/12/2024. Reply Expert Reports due by 10/10/2024. Expert Discovery due by 11/22/2024. Status Report due by 12/8/2023. Claim Construction Opening Brief due by 2/22/2024. Claim Construction Answering Brief due by 3/21/2024. Claim Construction Reply Brief due by 4/18/2024. Claim Construction Surreply Brief due by 5/9/2024. Joint Claim Construction Brief due by 5/16/2024. A Markman Hearing is set for 5/29/2024 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke. A Pretrial Conference is set for 9/4/2025 at 03:00 PM in Courtroom 6B before Judge Gregory B. Williams. A Bench Trial is set for 9/8/2025 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. Please see Order for further details and deadlines. Signed by Judge Christopher J. Burke on 11/2/2023. (dlb) (Entered: 11/02/2023) (16) |
| Oct 31, 2023 | 44 | PROPOSED ORDER Patent Case Scheduling Order by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 10/31/2023) (18) |
| Oct 30, 2023 | 41 | MOTION Defendants' Motion to Determine Relatedness to C.A. No. 20-1589-JFB-CJB and Transfer of Case to Judge Bataillon - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Proposed Order, # 2 7.1.1 Statement)Motions referred to Christopher J. Burke.(Phillips, John) (Entered: 10/30/2023) (0) |
| Oct 30, 2023 | 42 | OPENING BRIEF in Support re 41 MOTION Defendants' Motion to Determine Relatedness to C.A. No. 20-1589-JFB-CJB and Transfer of Case to Judge Bataillon filed by Lupin Ltd., Lupin Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 11/13/2023. (Phillips, John) (Entered: 10/30/2023) (11) |
| Oct 30, 2023 | 43 | DECLARATION re 41 MOTION Defendants' Motion to Determine Relatedness to C.A. No. 20-1589-JFB-CJB and Transfer of Case to Judge Bataillon of Carol Pitzel Cruz by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Phillips, John) (Entered: 10/30/2023) (0) |
| Oct 27, 2023 | 40 | STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Proposed Scheduling Order to November 1, 2023 (October 27, 2023) - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 10/27/2023) (2) |
| Oct 27, 2023 | N/A | SO ORDERED D.I. 40 STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Proposed Scheduling Order to November 1, 2023 (October 27, 2023) filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 10/27/2023. (mlc) (Entered: 10/27/2023) (0) |
| Oct 24, 2023 | 39 | Official Transcript of Case Management Conference held on 10/23/23 before Judge Christopher Burke. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/14/2023. Redacted Transcript Deadline set for 11/27/2023. Release of Transcript Restriction set for 1/22/2024. (Warner, Deanna) (Entered: 10/24/2023) (56) |
| Oct 23, 2023 | 38 | NOTICE of Appearance by Elizabeth A. DeFelice on behalf of Sandoz Inc. (DeFelice, Elizabeth) (Entered: 10/23/2023) (2) |
| Oct 23, 2023 | N/A | Minute Entry for proceedings held before Judge Christopher J. Burke - Scheduling/Case Management Conference held on 10/23/2023. The Court provided certain dates to the parties and guidance on the parties' disputes. The Court ordered the parties to meet and confer and to submit a revised proposed scheduling order by the close of business on October 27, 2023. (Clerk: A. Herman) Appearances: J. Leonard, V. Li, S. Roberts and D. Silver, for Plaintiffs; A. Cheek, C. Cruz, M. Friedrichs, J. Phillips and W. Zimmerman for Defendant Lupin Ltd.; E. DeFelice, T. Lavery and R. Waldron for Defendant Sandoz Inc.; and D. Abramowitz, C. Blessing and P. Kraman for Defendant Zydus Pharmaceuticals (USA) Inc. (Court Reporter Deanna Warner) (dlb) (Entered: 10/24/2023) (0) |
| Oct 18, 2023 | 37 | REDACTED VERSION of 35 Letter, by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 10/18/2023) (29) |
| Oct 13, 2023 | 36 | ORAL ORDER: The Court, having reviewed the parties' joint letter regarding a proposed scheduling order, (D.I. 35), hereby ORDERS that a scheduling conference pursuant to Fed. R. Civ. P. 16 will be held utilizing the Microsoft Teams platform October 23, 2023 at 1:45 p.m. before Judge Christopher J. Burke. By no later than October 16, 2023, the parties shall send an e-mail to the Court's Courtroom Deputy, Ms. Benyo, indicating the names and e-mail addresses of all individuals who will participate in the videoconference. Ordered by Judge Christopher J. Burke on 10/13/2023. (dlb) (Entered: 10/13/2023) (0) |
| Oct 11, 2023 | 35 | [SEALED] Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Scheduling Order Disputes and Three Most Significant Topics. (Attachments: # 1 Proposed Scheduling Order, # 2 Case Management Checklist)(Silver, Daniel) (Entered: 10/11/2023) (0) |
| Oct 6, 2023 | N/A | SO ORDERED D.I. 31 STIPULATION TO EXTEND TIME to submit (i) a copy of Judge Burke's Case Management Checklist, (ii) a Proposed Scheduling Order, and (iii) a joint letter to October 11, 2023 filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 10/6/2023. (mlc) (Entered: 10/06/2023) (0) |
| Oct 6, 2023 | 32 | NOTICE to Take Deposition of Plaintiffs Astellas Pharma Inc., Astellas Ireland Co., Ltd., and Astellas Pharma Global Development, Inc., pursuant to Rule 30(b)(6) of the Federal Rules of Civil Procedure on a mutually agreed upon date, time, and location by the parties filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) (Entered: 10/06/2023) (10) |
| Oct 6, 2023 | 33 | NOTICE OF SERVICE of 1) Zydus's Interrogatories to Plaintiffs (No. 1); and 2) Zydus's First Set of Requests for the Production of Documents and Things To Plaintiffs (No. 1) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) (Entered: 10/06/2023) (2) |
| Oct 6, 2023 | 34 | NOTICE OF SERVICE of 1) Defendants' Joint Interrogatories to Plaintiffs (Nos. 1 - 3); and 2) Defendants' Joint First Set of Requests for the Production of Documents and Things to Plaintiffs (Nos. 1 - 10) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) (Entered: 10/06/2023) (2) |
| Oct 5, 2023 | 31 | STIPULATION TO EXTEND TIME to submit (i) a copy of Judge Burke's Case Management Checklist, (ii) a Proposed Scheduling Order, and (iii) a joint letter to October 11, 2023 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Silver, Daniel) (Entered: 10/05/2023) (2) |
| Sep 25, 2023 | N/A | Pro Hac Vice Attorney Jayita Guhaniyogi for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | N/A | Pro Hac Vice Attorney Simon D. Roberts for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 09/25/2023) (0) |
| Sep 14, 2023 | N/A | Pro Hac Vice Attorney Simon D. Roberts for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 09/14/2023) (0) |
| Sep 13, 2023 | 29 | ANSWER to 17 Answer to Complaint, Counterclaim by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 09/13/2023) (5) |
| Sep 13, 2023 | 30 | ANSWER to 22 Answer to Complaint, Counterclaim by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 09/13/2023) (9) |
| Sep 8, 2023 | N/A | Pro Hac Vice Attorneys Steven J. Birkos and Rachel P. Waldron for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 09/08/2023) (0) |
| Sep 8, 2023 | N/A | Pro Hac Vice Attorney Kevin P. Burke for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 09/08/2023) (0) |
| Sep 7, 2023 | N/A | Pro Hac Vice Attorney William R. Zimmerman for Lupin Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 09/07/2023) (0) |
| Sep 7, 2023 | N/A | Pro Hac Vice Attorney Andrea L. Cheek for Lupin Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 09/07/2023) (0) |
| Sep 7, 2023 | 28 | ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burke's Case Management Checklist ("Checklist"). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order that is consistent with Judge Burke's "Rule 16 Scheduling Order--Patent" up through and including paragraph number 16 (i.e., regarding the portions of the case schedule leading up to but not including the case dispositive motion stage of the case) and that is consistent with paragraphs 13-24 of Judge Williams' "Rule 16 Scheduling Order--Patent (Non-ANDA)"(i.e., regarding the portions of the case schedule from the case dispositive motion stage through post-trial motions).; and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and both Scheduling Orders can be found on Judge Burke's/Judge Williams' portions of the District Court's website. Ordered by Judge Christopher J. Burke on 9/7/2023. (dlb) (Entered: 09/07/2023) (0) |
| Sep 5, 2023 | 27 | Letter to The Honorable Gregory B. Williams from Daniel M. Silver, Esq. regarding Court's August 16, 2023 Order. (Silver, Daniel) (Entered: 09/05/2023) (1) |
| Aug 31, 2023 | N/A | Pro Hac Vice Attorney Carol M. Pitzel Cruz for Lupin Ltd., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 08/31/2023) (0) |
| Aug 31, 2023 | N/A | Pro Hac Vice Attorney William A. Rakoczy for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 08/31/2023) (0) |
| Aug 31, 2023 | N/A | Pro Hac Vice Attorney Greg L. Goldblatt for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 08/31/2023) (0) |
| Aug 31, 2023 | N/A | Pro Hac Vice Attorneys Michael J. Gaertner, Carolyn A. Blessing, Jonathan B. Turpin, Emily L. Savas, David B. Abramowitz, Leah M. Brackensick for Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) (Entered: 08/31/2023) (0) |
| Aug 30, 2023 | N/A | SO ORDERED D.I. 26 MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Vincent Li, and Jayita Guhaniyogi filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc., D.I. 19 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Andrea L. Cheek, Carol Pitzel Cruz and Matthew S. Friedrichs filed by Lupin Ltd., Lupin Pharmaceuticals, Inc., D.I. 25 MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Rachel Pernic Waldron, Kevin P. Burke, Steven J. Birkos and Dr. Greg L. Goldblatt of Rakoczy Molino Mazzochi Siwik LLP filed by Sandoz Inc., and D.I. 24 MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing, Emily L. Savas, Jonathan B. Turpin, and Leah Brackensick filed by Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Limited. Ordered by Judge Christopher J. Burke on 8/30/2023. (dlb) (Entered: 08/30/2023) (0) |
| Aug 30, 2023 | N/A | Pro Hac Vice Attorney Vincent Li for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., and for Astellas Pharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (smg) (Entered: 08/30/2023) (0) |
| Aug 24, 2023 | 24 | MOTION for Pro Hac Vice Appearance of Attorney Michael J. Gaertner, David B. Abramowitz, Carolyn A. Blessing, Emily L. Savas, Jonathan B. Turpin, and Leah Brackensick - filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. Motions referred to Christopher J. Burke.(Stombaugh, Alexis) (Entered: 08/24/2023) (10) |
| Aug 24, 2023 | 25 | MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Rachel Pernic Waldron, Kevin P. Burke, Steven J. Birkos and Dr. Greg L. Goldblatt of Rakoczy Molino Mazzochi Siwik LLP - filed by Sandoz Inc.. Motions referred to Christopher J. Burke.(Gattuso, Dominick) (Entered: 08/24/2023) (8) |
| Aug 24, 2023 | N/A | SO ORDERED, re 16 STIPULATION TO EXTEND the deadline for the parties to meet and confer and file a letter of no more than one page, single-spaced, indicating whether they jointly agree to consent to Magistrate Judge Burke conducting all proceedings in this case to 9/5/23 filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Signed by Judge Gregory B. Williams on 8/24/23. (ntl) (Entered: 08/24/2023) (0) |
| Aug 24, 2023 | 26 | MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Vincent Li, and Jayita Guhaniyogi - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Certifications)Motions referred to Christopher J. Burke.(Joyce, Alexandra) (Entered: 08/24/2023) (0) |
| Aug 23, 2023 | 16 | STIPULATION TO EXTEND TIME the deadline for the parties to meet and confer and file a letter of no more than one page, single-spaced, indicating whether they jointly agree to consent to Magistrate Judge Burke conducting all proceedings in this case to September 5, 2023 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Joyce, Alexandra) (Entered: 08/23/2023) (2) |
| Aug 23, 2023 | 17 | ANSWER to 1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Lupin Pharmaceuticals, Inc., Lupin Ltd..(Phillips, John) (Entered: 08/23/2023) (22) |
| Aug 23, 2023 | 18 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals, Inc. filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) (Entered: 08/23/2023) (2) |
| Aug 23, 2023 | 19 | MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, Andrea L. Cheek, Carol Pitzel Cruz and Matthew S. Friedrichs - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: # 1 Certification of William R. Zimmerman, # 2 Certification of Andrea L. Cheek, # 3 Certification of Carol Pitzel Cruz, # 4 Certification of Matthew S. Friedrichs)Motions referred to Christopher J. Burke.(Haney, Megan) (Entered: 08/23/2023) (0) |
| Aug 23, 2023 | 20 | ANSWER to 1 Complaint, and Affirmative Defenses by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar) (Entered: 08/23/2023) (24) |
| Aug 23, 2023 | 21 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zydus Lifesciences Limited for Zydus Pharmaceuticals (USA) Inc. filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar) (Entered: 08/23/2023) (4) |
| Aug 23, 2023 | 22 | ANSWER to 1 Complaint, , COUNTERCLAIM against All Plaintiffs by Sandoz Inc..(Gattuso, Dominick) (Entered: 08/23/2023) (30) |
| Aug 23, 2023 | 23 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Sandoz Inc. filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 08/23/2023) (2) |
| Aug 16, 2023 | 15 | ORAL ORDER: IT IS HEREBY ORDERED that the above-captioned case is referred to Magistrate Judge Christopher J. Burke to hear and resolve all pre-trial matters up to and including expert discovery matters (but not including summary judgment motions, Daubert motions, pre-trial motions in limine or the pre-trial conference), subject to 28 U.S.C. § 636(b) and any further Order of the Court. IT IS ALSO HEREBY ORDERED that, by no later than ten (10) days from today's date, the parties shall meet and confer and file a letter of no more than one page, single-spaced, indicating whether they jointly agree to consent to Magistrate Judge Burke conducting all proceedings in this case. ORDERED by Judge Gregory B. Williams on 8/16/23. (ntl) (Entered: 08/16/2023) (0) |
| Aug 4, 2023 | 9 | DECLARATION of Service on Lupin Ltd. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit A-B)(Joyce, Alexandra) (Entered: 08/04/2023) (0) |
| Aug 4, 2023 | 10 | SUMMONS Returned Executed by Astellas Pharma Global Development, Inc., Astellas Ireland Co., Ltd., Astellas Pharma Inc..Lupin Pharmaceuticals, Inc. served on 8/2/2023, answer due 8/23/2023. (Joyce, Alexandra) (Entered: 08/04/2023) (1) |
| Aug 4, 2023 | 11 | SUMMONS Returned Executed by Astellas Pharma Global Development, Inc., Astellas Ireland Co., Ltd., Astellas Pharma Inc..Sandoz Inc. served on 8/2/2023, answer due 8/23/2023. (Joyce, Alexandra) (Entered: 08/04/2023) (1) |
| Aug 4, 2023 | 12 | DECLARATION of Service on Zydus Pharmaceuticals (USA) Inc. by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc.. (Attachments: # 1 Exhibit A-B)(Joyce, Alexandra) (Entered: 08/04/2023) (0) |
| Aug 4, 2023 | 13 | WAIVER OF SERVICE returned executed by Astellas Pharma Global Development, Inc., Astellas Ireland Co., Ltd., Astellas Pharma Inc.: For Zydus Lifesciences Limited waiver sent on 8/3/2023, answer due 10/2/2023. (Joyce, Alexandra) (Entered: 08/04/2023) (1) |
| Aug 4, 2023 | 14 | Letter to The Honorable Gregory B. Williams from Pilar G. Kraman regarding Defendants' Responsive Letter regarding Notice of Related Cases - re 7 Notice (Other). (Kraman, Pilar) (Entered: 08/04/2023) (2) |
| Aug 3, 2023 | 7 | NOTICE of Related Actions by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc. (Kraman, Pilar) (Entered: 08/03/2023) (2) |
| Aug 3, 2023 | 8 | Letter to The Honorable Gregory B. Williams from Daniel M. Silver, Esq. regarding Response to Notice of Related Cases - re 7 Notice (Other). (Silver, Daniel) (Entered: 08/03/2023) (2) |
| Aug 2, 2023 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 08/02/2023) (0) |
| Jul 28, 2023 | 1 | Complaint* (1) |
| Jul 28, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 07/31/2023) (3) |
| Jul 28, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Lupin Ltd. and Lupin Pharmaceuticals, Inc. on August 25, 2016, Sandoz Inc. on September 9, 2016, and Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited on September 6, 2016. Thirty Month Stay Deadline: Not Applicable. Date of Expiration of Patent: September 28, 2029. (jfm) (Entered: 07/31/2023) (2) |
| Jul 28, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,707,451. (jfm) (Entered: 07/31/2023) (1) |
| Jul 28, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US Holding, Inc. for Astellas Pharma Global Development, Inc.; Corporate Parent Astellas B.V. for Astellas Ireland Co., Ltd. filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc. (jfm) (Entered: 07/31/2023) (2) |
| Jul 28, 2023 | 6 | Summons Issued as to Lupin Ltd., Lupin Pharmaceuticals, Inc., Sandoz Inc., Zydus Lifesciences Limited, and Zydus Pharmaceuticals (USA) Inc. on 7/28/2023. (Attachments: # 1 Summons Issued Lupin Pharmaceuticals, Inc., # 2 Summons Issued Sandoz Inc., # 3 Summons Issued Zydus Pharmaceuticals (USA) Inc, # 4 Summons Issued Zydus Lifesciences Limited)(jfm) (Entered: 07/31/2023) (0) |
